Understanding the power of blood and bone marrow derived solutions
Blood as well as the bone marrow are a very complex and dynamic substances, that contain a lot of morphological and cellular components. Importantly, those cellular components are responsible for many fundamental processes in human body, as they are able control and regulate numerous of biological processes at the molecular level. Consequently, this potential of blood and bone marrow cellular components can be applied and serve its beneficial role in regenerative therapies in wide range of pathological conditions.
In Biovico, our approach involves finding the way to effectively and precisely extract and leverage specific elements from blood and bone marrow in order to develop advanced therapies that hold great promise for the medical community.
Key cellular components that have potential in regenerative medicine:
1. Platelets (PLTs): Platelets, also known as thrombocytes, are small cell fragments derived from megakaryocytes that contain enormous amount of biologically active proteins called growth factors. While PLTs primary role is hemostasis regulation, recent advancements in regenerative medicine have unveiled the potential of PLTs in promoting tissue repair and regeneration. Our research and development efforts focus on widening and expanding the power of therapies based on the delivery the PLTs regenerative potential in different pathological conditions, ranging from musculoskeletal or autoimmune disease to even different metabolic disorders.
2. Fibrin scaffold with blood components entrapped within: Blood has a unique ability to activate its cellular and protein factors in order to polymerize fibrinogen and form insoluble fibrin scaffold that will entrap different cellular blood components- including PLTs that release growth factors. As a result, expertly created and properly concentrated fibrillar scaffold can serve as stable construct with an unique regenerative potential. This potential can be used in pathological conditions where elongated release of growth factors from mechanically stable fibrin construct is required.
3. Mesenchymal Stem Cells or Medicinal Signaling cells (MSC): Human bone marrow (BM) is a fundamental source of self-renewal potential for an adult body. BM contains not only Hematopoietic stem cells (HSC) and by this it is responsible for the production and renewal of the whole blood cell lineage pule but it also serves as a source of an adult, somatic stem cells called Mesenchymal stem cells or Medicinal Signaling cells (MSC). These cells that can differentiate into various cell types of the mesodermal lineage, including osteoblasts (bone cells), chondrocytes (cartilage cells), and adipocytes (fat cells). Mesenchymal stem cells (MSCs) hold significant potential in modern medicine, and their versatile characteristics have paved the way for various therapeutic applications, including:
I. Tissue Repair and Regeneration:
II. Autoimmune and Inflammatory Disorders:
III. Cardiovascular Diseases:
IV. Neurological Disorders:
V. Wound Healing and Dermatology:
VI. Gene Therapy and Drug Delivery:
VII. Anti-Aging and Aesthetic Medicine:
Our vision for cell based blood and bone marrow derived solutions
The development of new and unique blood and bone marrow-derived solutions aligns with Biovico's commitment to providing targeted, efficacious, and patient-centric therapies based on patient's own material, releasing its own healing potential. In Biovico, by unlocking the therapeutic potential of PLTs and MSCs, we aspire to revolutionize the treatment landscape across various medical disciplines.
With our knowledge about blood and bone marrow processing we have created a whole family of the devices that can effectively and precisely concentrate and boost their regenerative potential in order to create and deliver effective, injectable products, for various, very specific applications requiring unique approach.
Anticipated Impact on Healthcare
The introduction of blood and bone marrow-derived solutions marks a significant leap forward in human healthcare. Biovico envisions these therapies contributing to personalized medicine, offering tailored treatments that address the unique needs of individual patients from his own cells and tissues. This initiative not only exemplifies our dedication to advancing patient care but also reinforces Biovico's commitment to shaping the future of medicine.
As we embark on this groundbreaking venture, Biovico remains steadfast in its pursuit of excellence. Stay tuned for updates on our progress as we strive to bring forth transformative blood-derived solutions that have the potential to redefine the landscape of medical treatments. Together, let's usher in a new era of healthcare innovation.